PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32878784-4	2020	RESULTS: CEP1347 selectively inhibited the growth of retinoblastoma cell lines expressing murine double minute 4 (MDM4), a P53 inhibitor.	3,9-bis((ethylthio)methyl)-K-252a	9-16	transformation related protein 53, pseudogene	Mus musculus	123-126	
32878784-5	2020	Furthermore, CEP1347 reduced the expression of MDM4 and activated the P53 pathway in MDM4-expressing retinoblastoma cells, which was required for the inhibition of their growth by CEP1347.	3,9-bis((ethylthio)methyl)-K-252a	13-20	transformation related protein 53, pseudogene	Mus musculus	70-73	
32878784-5	2020	Furthermore, CEP1347 reduced the expression of MDM4 and activated the P53 pathway in MDM4-expressing retinoblastoma cells, which was required for the inhibition of their growth by CEP1347.	3,9-bis((ethylthio)methyl)-K-252a	180-187	transformation related protein 53, pseudogene	Mus musculus	70-73	
32878784-6	2020	CONCLUSION: We propose CEP1347 as a promising candidate for the treatment of retinoblastomas, where functional inactivation of P53 as a result of MDM4 activation is reportedly common.	3,9-bis((ethylthio)methyl)-K-252a	23-30	transformation related protein 53, pseudogene	Mus musculus	127-130